Digital Content 
NEWS #PharmaBuzz
24 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/24/3104106/18362/en/Amarin-Announces-Exclusive-License-and-Supply-Agreement-with-Recordati-to-Commercialize-VAZKEPA-Icosapent-Ethyl-in-Europe.html
18 Jun 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-18-2025-14246.pdf
31 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/31/3052239/18362/en/Amarin-Highlights-Recent-Data-Presented-at-ACC-25-Evaluating-Mechanistic-Effects-of-Eicosapentaenoic-Acid-EPA-in-Lp-a-Enriched-Plasma-and-in-Combination-with-GLP-1-Agonist.html
27 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/27/3033894/18362/en/Amarin-Marks-Key-Milestone-for-VASCEPA-VAZKEPA-Icosapent-Ethyl-Publication-of-Post-Hoc-Analysis-of-REDUCE-IT-in-Journal-of-the-American-Heart-Association-Reports-Benefit-on-Top-of-.html
25 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/25/3031955/18362/en/Amarin-Receives-National-Reimbursement-for-VAZKEPA-in-Austria.html
20 Nov 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218899
Share 